Patients with multiple myeloma – What happens in second line after first-line refractory to daratumumab? Data from the German MYRIAM registry

Nusch, A., Burkhard-Meier, U., Jacobasch, L., Linde, H., Uhlig, J., Welslau, M., Tech, S., Medinger, T., Jänicke, M., Dechow, T., Einsele, H., Engelhardt, M., Knauf, W., Marschner, P., 2024
Oncol Res Treat (2024) 47 (Suppl. 2) (P741): p. 241

Download